Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GERCOR - Multidisciplinary Oncology Cooperative Group
Eastern Cooperative Oncology Group
University of California, San Francisco
Rutgers, The State University of New Jersey
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Stanford University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
East and North Hertfordshire NHS Trust